India Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

India Pharmaceuticals and Healthcare Report Q3 2013 Jul 17th 2013, 00:00, by rnrmahesh BMI View: Despite slowing growth in the Indian pharmaceutical market in the first four months of 2013, top domestic firms continued to see strong double-digit growth in the latest quarter, outperforming multinational pharmaceutical firms. We maintain that the Indian government’s cost concerns will continue to hinder revenue growth for multinational pharmaceutical firms, benefiting the domestic industry. In foreign markets, Indian pharmaceutical firms will have to be more vigilant with manufacturing practices or risk suffering losses due to drug recalls. Headline Expenditure Projections Pharmaceuticals: INR840bn (US$15.7bn) in 2012 to INR926.1bn (US$17.0bn) in 2013; +10.3% in local currency terms and +8.3% in … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=107769. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/india-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions